Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer
Frédéric Di Fiore(Université Paris Cité), Pierre Michel(Aix-Marseille Université), Philippe Ducrotté(Hôpital Charles-Nicolle), Olivier Rigal(Centre Henri Becquerel), Stéphane Lecleire(Inserm), H. Hamidou(Laboratoire National Henri Becquerel), Daniela Pop(Université de Rouen Normandie), Éric Lerebours, B Paillot(Centre Henri Becquerel)
Cited by 183
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
|The Lancet Oncology|2014|451
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
|European Journal of Cancer|1997|347
The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype
|The American Journal of Gastroenterology|2011|290
European society of neurogastroenterology and motility guidelines on functional constipation in adults
|Neurogastroenterology & Motility|2019|233